Education
About Us
Working with TipRanks
Follow Us
Saniona AB (SE:SANION)
:SANION
SANION Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr1.80 - kr9.91
Previous CloseN/A
Volume191.43K
Average Volume (3M)465.53K
Market Cap
kr1.07B
Enterprise Valuekr791.42M
Total Cash (Recent Filing)kr303.26M
Total Debt (Recent Filing)kr10.50M
Price to Earnings (P/E)4.9
Beta-0.24
Next Earnings
May 28, 2025EPS EstimateN/A
Last Dividend Ex-Date
Oct 20, 2016Dividend YieldN/A
Share Statistics
EPS (TTM)2.21
Shares Outstanding135,521,840
10 Day Avg. Volume568,346
30 Day Avg. Volume465,534
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)3.86
Price to Sales (P/S)0.00
P/FCF Ratio4.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Saniona AB News
---
SANION FAQ
What was Saniona AB’s price range in the past 12 months?
Saniona AB lowest stock price was kr1.80 and its highest was kr9.91 in the past 12 months.
What is Saniona AB’s market cap?
Saniona AB’s market cap is kr1.07B.
When is Saniona AB’s upcoming earnings report date?
Saniona AB’s upcoming earnings report date is May 28, 2025 which is in 13 days.
How were Saniona AB’s earnings last quarter?
Saniona AB released its earnings results on Feb 27, 2025. The company reported kr2.209 earnings per share for the quarter, beating the consensus estimate of N/A by kr2.209.
Is Saniona AB overvalued?
According to Wall Street analysts Saniona AB’s price is currently Overvalued.
Does Saniona AB pay dividends?
Saniona AB pays a Notavailable dividend of kr0.1 which represents an annual dividend yield of N/A. See more information on Saniona AB dividends here
What is Saniona AB’s EPS estimate?
Saniona AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Saniona AB have?
Saniona AB has 135,521,840 shares outstanding.
What happened to Saniona AB’s price movement after its last earnings report?
Saniona AB reported an EPS of kr2.209 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -11.056%.
Which hedge fund is a major shareholder of Saniona AB?
Currently, no hedge funds are holding shares in SE:SANION
---
Company Description
Saniona AB
Saniona AB (publ), a rare disease biopharmaceutical company, engages in the research, development, and commercialization of treatments for the central nervous system in Denmark. The company's products include Tesofensine, a monoamine reuptake inhibitor; and Tesomet, a fixed dose combination of tesofensine and metoprolol that has completed the Phase 2 clinical trials for the treatment of prader-willi syndrome and hypothalamic obesity. It also develops SAN711, which is in Phase 1 clinical stage for rare neuropathic disorders; SAN903 that is in preclinical stage for rare inflammatory, fibrotic, and hematological disorders. The company has research and collaboration agreements with Boehringer Ingelheim International GmbH; license agreement with Productos Medix, S.A. de C.V.; research services agreement and a collaboration agreement with Cephagenix ApS. Saniona AB (publ) was founded in 2011 and is headquartered in Glostrup, Denmark.
---
Technical Analysis
Guard Therapeutics International AB
―
IRLAB Therapeutics AB Class A
―
Xbrane Biopharma AB
―
Xspray Pharma AB
―
SynAct Pharma AB
―
---